The Efficacy and Safety of Puerarin in Obesity Treatment

NCT06968208 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Metabolic Diseases
Obesity/Therapy

Interventions

DRUG: Puerarin
DRUG: Placebo

Sponsor

Ruijin Hospital